Our NCI RO1 received a 1.0 percentile score!!!

hassanalaliphd
Apr 11
1 min read

Our NCI R01 (Schatz, Ali) received a 1 percentile score. This grant aims to study the essential role of the cyclin-G associated kinase (GAK) in diffuse large B-cell lymphoma (DLBCL) progression. We discovered GAK as a drug target for DLBCL using our in-house idTRAX technology. This new funding will support our ongoing work to understand the mechanism surrounding GAK and ultimately developing a new drug candidate for DLBCL.

Recent Posts

See All

New DoD Funding

The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...

New State of Florida Funding

The Ali Lab, in collaboration with the Brambilla lab, received new funding from the State of Florida. The goal of this program is to...

New DoD funding to tackle Neurotrauma research

A team from the Miami Project to Cure Paralysis, including the Ali Lab, Received DoD funding to tackle Neurotrauma research. Read more at...

The Ali Lab at the University of Miami

Our NCI RO1 received a 1.0 percentile score!!!

Recent Posts

Comments